Is your screening campaign stuck? 3 signs that it’s time to look for an alternative biophysical technology
Follow these 7 tips when pipetting small volumes to get consistent assay results
6 protein degradation conferences in 2021 you can’t afford to miss
3 case studies on how to characterize challenging drug discovery targets — membrane proteins, peptide libraries, and PROTACs
The NanoTemper Story – Chapter 5: The Dianthus
3 big takeaways from SLAS on the future of automation and screening
When aptamers are the better choice over mAbs
6 ingredients for a successful fragment library
What are PROTACs: the game-changing modality that promises to tackle undruggable proteins
